AI Analysis AI Analysis of NVO
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Novo Nordisk A/S stock upgraded from Sell Candidate to Buy Candidate after Monday trading session
(Updated on May 12, 2025)

Buy candidate since May 12, 2025

The Novo Nordisk A/S stock price gained 3.00% on the last trading day (Monday, 12th May 2025), rising from $65.77 to $67.74. During the last trading day the stock fluctuated 5.79% from a day low at $64.04 to a day high of $67.75. The price has risen in 6 of the last 10 days and is up by 8.18% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 million more shares were traded than the day before. In total, 18 million shares were bought and sold for approximately $1.20 billion.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $66.36, a level that may pose a second chance to hit a runner. According to fan-theory $82.29 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

NVO Signals & Forecast

The Novo Nordisk A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $67.22 and $65.65. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 02, 2025, and so far it has fallen -2.15%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

Novo Nordisk A/S finds support from accumulated volume at $65.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.71 between high and low, or 5.79%. For the last week, the stock has had daily average volatility of 3.70%.

Our recommended stop-loss: $64.87 (-4.24%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (NVO) For The Upcoming Trading Day Of Tuesday 13th

For the upcoming trading day on Tuesday, 13th we expect Novo Nordisk A/S to open at $66.51, and during the day (based on 14 day Average True Range), to move between $64.84 and $70.64, which gives a possible trading interval of +/-$2.90 (+/-4.28%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 8.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $69.23 (2.20%) than the support at $65.60 (3.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novo Nordisk A/S stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.779 Buy Candidate Upgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on May 13, 2025 - $66.51 ( 1.82%).

NVO Performance

Trading levels for NVO

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 70.22 3.66%
R2 68.80 1.57%
R1 67.93 0.276%
Price 67.74
S1 65.09 -3.91%
S2 64.22 -5.20%
S3 62.80 -7.29%

Accumulated Volume Support & Resistance Levels

Level Price
R3 78.95 16.55%
R2 78.83 16.37%
R1 69.23 2.20%
Price 67.74
S1 65.60 -3.16%
S2 63.64 -6.05%
S3 58.08 -14.26%

NVO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 05, 2025 Mar 31, 2025 Apr 08, 2025 $0.787 1.28%
2 Aug 16, 2024 Aug 16, 2024 Aug 26, 2024 $0.374 0.277%
3 Jan 31, 2024 Mar 22, 2024 Apr 02, 2024 $0.93 0.735%
4 Aug 10, 2023 Aug 18, 2023 Aug 29, 2023 $0.88 0.93%
5 Feb 02, 2023 Mar 24, 2023 Apr 04, 2023 $1.19 1.50%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NVO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Novo Nordisk A/S Stock?
Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the May 12, 2025, the price of an Novo Nordisk A/S (NVO) share was $67.74.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $148.15 and the 52-week low is $57.00.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the May 12, 2025, the market capitalization of Novo Nordisk A/S is 293.803B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is Aug 06, 2025.
Click to get the best stock tips daily for free!
ABOUT NOVO NORDISK A/S
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ...
GOLDEN STAR
Ticker Change Signal Date
MEDP
$300.81
4.30% May 08
BAX
$30.72
3.78% May 07
HBM
$7.41
12.42% May 05
P
PENG
$17.23
9.75% May 05
E
EXE
$105.88
4.76% May 02

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE